phenoxybenzamine has been researched along with MEA 2a in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iglesias, P | 1 |
| Santacruz, E | 1 |
| García-Sancho, P | 1 |
| Marengo, AP | 1 |
| Guerrero-Pérez, F | 1 |
| Pian, H | 1 |
| Fajardo, C | 1 |
| Villabona, C | 1 |
| Díez, JJ | 1 |
| Joseph, JV | 1 |
| Harrison, R | 1 |
| Davis, RS | 1 |
2 other studies available for phenoxybenzamine and MEA 2a
| Article | Year |
|---|---|
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Age | 2021 |
Multiple endocrine neoplasia type IIA (Sipple's syndrome) presenting in pregnancy.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antihypertensive Agents; Calcitonin; Drug Monitoring; | 2000 |